Gene · 1301
Papers2,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathobiology of the crystalline lens in Stickler syndrome. | Prog Retin Eye Res | 2024 | 39349161 | PubTator, text mining | PubMed |
| CAF-Associated Genes in Breast Cancer for Novel Therapeutic Strategies. | Biomedicines | 2024 | 39335478 | PubTator, text mining | PubMed |
| Highly efficient CRISPR-mediated genome editing through microfluidic droplet cell mechanoporation. | Nat Commun | 2024 | 39284842 | PubTator, text mining | PubMed |
| Comprehensive proteomic characterization of urethral stricture disease in the Chinese population. | Front Mol Biosci | 2024 | 39130371 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk RNA sequencing identifies POSTN as a potential biomarker and therapeutic target for rheumatoid arthritis. | Gene | 2024 | 39067546 | PubTator, text mining | PubMed |
| Mutational and transcriptional profile predicts the prognosis of stage IV gastric cancer - Prognostic factors for metastatic gastric cancer. | Arab J Gastroenterol | 2024 | 39043541 | PubTator, text mining | PubMed |
| Molecular pathogenesis of microsatellite instability-high early-stage colorectal adenocarcinoma in India. | Drug Metab Pers Ther | 2024 | 39042905 | PubTator, text mining | PubMed |
| Coenzyme Q-10 reduced the aberrant production of extracellular matrix proteins in uterine leiomyomas through transforming growth factor beta 3. | F S Sci | 2024 | 39004304 | PubTator, text mining | PubMed |
| POLM variant G312R promotes ovarian tumorigenesis through genomic instability and COL11A1-NF-κB axis. | Am J Physiol Cell Physiol | 2024 | 38826139 | PubTator, text mining | PubMed |
| Unlocking cellular plasticity: enhancing human iPSC reprogramming through bromodomain inhibition and extracellular matrix gene expression regulation. | Stem Cells | 2024 | 38825983 | PubTator, text mining | PubMed |
| Overexpression of COL11A1 confers tamoxifen resistance in breast cancer. | NPJ Breast Cancer | 2024 | 38806505 | PubTator, text mining | PubMed |
| A novel compound heterozygous variant of the COL11A1 gene in a patient with fibrochondrogenesis type I: the first case in Korea. | Ann Pediatr Endocrinol Metab | 2024 | 38712494 | PubTator, text mining | PubMed |
| Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression. | Nat Commun | 2024 | 38702309 | PubTator, text mining | PubMed |
| [Prenatal phenotype and genetic analysis of a fetus with Fibrochondrogenesis 1 due to compound heterozygous variants of COL11A1 gene]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2024 | 38684309 | PubTator, text mining | PubMed |
| A liquid biopsy assay for the noninvasive detection of lymph node metastases in T1 lung adenocarcinoma. | Thorac Cancer | 2024 | 38682829 | PubTator, text mining | PubMed |
| Clinical and Molecular Characterization of a Novel Homozygous Frameshift Variant in AEBP1-Related Classical-like Ehlers Danlos Syndrome Type 2 with Comparison to Previously Reported Rare Cases. | Genes (Basel) | 2024 | 38674395 | PubTator, text mining | PubMed |
| Analysis of cancer-associated fibroblasts related genes identifies COL11A1 associated with lung adenocarcinoma prognosis. | BMC Med Genomics | 2024 | 38649961 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis reveals upregulated extracellular matrix hub genes in pancreatic cancer: Implications for diagnosis, prognosis, immune infiltration, and therapeutic strategies. | Cancer Rep (Hoboken) | 2024 | 38639039 | PubTator, text mining | PubMed |
| Genetic Associations of Primary Angle-Closure Disease: A Systematic Review and Meta-Analysis. | JAMA Ophthalmol | 2024 | 38546604 | PubTator, text mining | PubMed |
| [Features of genetic mutations in children with high myopia combined with peripheral retinal degenerations]. | Vestn Oftalmol | 2024 | 38450462 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1301/papers?page=9